Journal
BREAST CANCER RESEARCH
Volume 14, Issue 2, Pages -Publisher
BMC
DOI: 10.1186/bcr3132
Keywords
-
Categories
Funding
- NIH [P41-RR008079]
Ask authors/readers for more resources
An emerging clinical modality called proton magnetic resonance spectroscopy (H-1-MRS) enables the non-invasive in vivo assessment of tissue metabolism and is demonstrating applications in improving the specificity of MR breast lesion diagnosis and monitoring tumour responsiveness to neoadjuvant chemotherapies. Variations in the concentration of choline-based cellular metabolites, detectable with H-1-MRS, have shown an association with malignant transformation of tissue in in vivo and in vitro studies. H-1-MRS exists as an adjunct to the current routine clinical breast MR examination. This review serves as an introduction to the field of breast H-1-MRS, discusses modern high-field strength and quantitative approaches and technical considerations, and reviews the literature with respect to the application of H-1-MRS for breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available